Datavault AI Issues Formal Response To Wolfpack Research's Malicious Short Report Company Affirms The Strength Of Its Intellectual Property, Leadership, And Strategic Direction
1. The Wolfpack Research Report Contains False and Defamatory Claims Aimed at Manipulating DVLT Stock for Financial Gain
The Wolfpack Research report includes numerous false, misleading, and defamatory statements intended to manipulate Datavault AI's stock for the financial benefit of short sellers.
These claims lack factual foundation and have caused reputational harm to the Company and its stockholders. Wolfpack Research has openly acknowledged its short position in DVLT shares-demonstrating that its so-called“research” is driven by self-interest rather than truth.
“It's obvious that these actors are financially benefitting from spreading false information,” said Nathaniel Bradley, Chief Executive Officer of Datavault AI.“We intend to file suit to hold Wolfpack Research accountable for its malicious conduct and to protect the rights of our shareholders.”
Short selling is a recognized market practice; however, intentional market manipulation through false and defamatory statements is not. The Company is evaluating Wolfpack Research's actions and will pursue all legal remedies available under applicable law.
2. Datavault AI Has Engaged Legal Counsel and Formally Demanded Wolfpack Research Cease and Desist its Tortious Conduct
Datavault AI has retained Paul Hastings LLP and Dickinson Wright PLLC to advise on litigation strategy and regulatory action. The Company is evaluating its legal rights and intends to pursue all available remedies to protect its reputation and the legitimate interests of its stockholders.
Jacob Frenkel, Securities Enforcement Practice Chair at Dickinson Wright PLLC and lead litigation counsel for Datavault AI, stated:“the proper place for such purveyors and backers of 'short and distort' content is in a defendant's chair in a courtroom, and that is exactly where the Company intends to put Wolfpack Research. Such abusive, fraudulent and manipulative practices mislead the market, sow distrust and harm shareholders. Mr. Bradley is committed to acting with the best interest of his Company's shareholders, which is the precise reason for pursuing legal recourse against such defamatory report-writers. The lawsuit will spell out the false and misleading statements with specificity to the point of being a roadmap for federal enforcement authorities also to put the authors and instigators of the Wolfpack Research report in a defendant's chair.”
3. Datavault AI Reaffirms the Strength of Its Intellectual Property and Strategic Value
Datavault AI's value is anchored in its robust intellectual property portfolio, which comprises over 70 U.S. and international patents covering AI-driven data valuation, inaudible audio signal technology, blockchain tokenization frameworks, and enterprise data monetization systems.
“Our strategy is rooted in IP and execution, not speculation,” said Bradley.“The technology we've developed is already creating value across industries -from digital identity and healthcare to acoustic data and real-world asset tokenization. That foundation is unshakable.”
Datavault's IP portfolio provides licensing revenue opportunities and a formidable barrier to entry for competitors. Recent patent grants include those covering carbon-credit tokenization on blockchain, virtual-reality data integration, and AI-driven audio tracking systems.
4. Professional History of Nathaniel T. Bradley
Nathaniel T. Bradley is a prolific American inventor and entrepreneur with more than two decades of experience in mobile marketing, audio processing, AI, and data monetization. He founded AudioEye, Inc. (NASDAQ: AEYE), pioneering digital accessibility technology used worldwide, and later Augme Technologies / Hipcricket, a mobile advertising platform that served Fortune 500 clients. Bradley was recognized as an EY Entrepreneur of the Year Finalist and received the Edison Gold Award for Social Impact.
At Datavault AI, Bradley has led the development of innovations in AI data valuation, blockchain for real-world asset (RWA) tokenization, and AI-powered audio communication through the Company's ADIO® technology. His reputation for building mission-driven, patent-protected platforms is widely recognized across both technology and capital markets.
5. Recent Successes and Milestones
About Datavault AI Inc.
Datavault AITM (Nasdaq: DVLT) is at the forefront of AI-driven data experiences, valuation, and monetization. The company's cloud-based platform delivers comprehensive solutions with a collaborative emphasis across its Acoustic Science and Data Science Divisions. Datavault AI's Acoustic Science Division features Wisam®, ADIO®, and Sumerian® patented technologies, along with industry-leading foundational spatial and multichannel wireless HD sound transmission technologies, including IP for audio timing, synchronization, and multi-channel interference cancellation. The Data Science Division harnesses high-performance computing to offer solutions for experiential data perception, valuation, and secure monetization. Datavault AI's cloud-based platform serves diverse industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy, and more. The Information Data Exchange® (IDE) enables Digital Twins and licensing of name, image, and likeness (NIL) by securely linking physical real-world objects to immutable metadata, promoting responsible AI with integrity. Datavault AI's technology suite is fully customizable, featuring AI and Machine Learning (ML) automation, third-party integrations, detailed analytics, marketing automation, and advertising monitoring. The company is headquartered in Beaverton, OR. Learn more at .
Forward-Looking Statements
Certain statements and information included in this press release constitute“forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases“will,”“will likely result,”“expected to,”“will continue,”“anticipated,”“estimate,”“projected,”“intend,”“goal,” or similar expressions are intended to identify“forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Forward-looking statements in this press release include, without limitation, those related to the Company's planned actions against Wolfpack Research, the Company's prospects and licensing revenue opportunities. Such uncertainties and risks include, but are not limited to, the results of our planned actions against Wolfpack Research, our ability to successfully execute our growth strategy, changes in laws or regulations, economic conditions, dependence on management, demand for products and services of the Company, newly developing technologies, the Company's ability to compete, regulatory matters, protection of technology, competitive factors, and other factors discussed in the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q that the Company has filed or may subsequently file with the U.S. Securities and Exchange Commission. Any forward-looking statements contained in this press release are based on the current expectations of the Company's management team and speak only as of the date hereof, and the Company specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.
Corporate Communications
IBN
Austin, Texas
512.354.7000 Office
...
Media Contact:
...

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment